Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis.
Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Adachi J, Wells G, Shea B, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Cranney A, et al. Among authors: robinson v. Endocr Rev. 2002 Aug;23(4):524-8. doi: 10.1210/er.2001-4002. Endocr Rev. 2002. PMID: 12202467 Review.
Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women.
Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Cranney A, et al. Among authors: robinson v. Endocr Rev. 2002 Aug;23(4):508-16. doi: 10.1210/er.2001-2002. Endocr Rev. 2002. PMID: 12202465 Review.
Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis.
Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, Robinson V, Shea B, Wells G, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Cranney A, et al. Among authors: robinson v. Endocr Rev. 2002 Aug;23(4):517-23. doi: 10.1210/er.2001-3002. Endocr Rev. 2002. PMID: 12202466 Review.
Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women.
Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, Robinson V, Henry D, O'Connell D, Cranney A; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Wells G, et al. Among authors: robinson v. Endocr Rev. 2002 Aug;23(4):529-39. doi: 10.1210/er.2001-5002. Endocr Rev. 2002. PMID: 12202468 Review.
Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis.
Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Shea B, Wells G, Adachi J, Waldegger L, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Cranney A, et al. Among authors: robinson v. Endocr Rev. 2002 Aug;23(4):540-51. doi: 10.1210/er.2001-6002. Endocr Rev. 2002. PMID: 12202469 Review.
Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis.
Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Shea B, et al. Among authors: robinson v. Endocr Rev. 2002 Aug;23(4):552-9. doi: 10.1210/er.2001-7002. Endocr Rev. 2002. PMID: 12202470 Review.
Risedronate for the prevention and treatment of postmenopausal osteoporosis.
Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G. Cranney A, et al. Among authors: robinson v. Cochrane Database Syst Rev. 2003;(4):CD004523. doi: 10.1002/14651858.CD004523. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. doi: 10.1002/14651858.CD004523.pub2. PMID: 14584020 Updated. Review.
WITHDRAWN: Etidronate for treating and preventing postmenopausal osteoporosis.
Cranney A, Adachi JD, Griffith L, Guyatt G, Krolicki N, Robinson VA, Shea BJ, Wells G. Cranney A, et al. Among authors: robinson va. Cochrane Database Syst Rev. 2007 Jul 18;(1):CD003376. doi: 10.1002/14651858.CD003376.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636719 Review.
WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.
Cranney A, Adachi JD, Guyatt G, Papaioannou A, Robinson VA, Shea BJ, Tugwell P, Waldegger LM, Weaver B, Wells G, Zytaruk N. Cranney A, et al. Among authors: robinson va. Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. doi: 10.1002/14651858.CD004523.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004523. doi: 10.1002/14651858.CD004523.pub3. PMID: 17636764 Updated. Review.
Exercise for preventing and treating osteoporosis in postmenopausal women.
Bonaiuti D, Shea B, Iovine R, Negrini S, Robinson V, Kemper HC, Wells G, Tugwell P, Cranney A. Bonaiuti D, et al. Among authors: robinson v. Cochrane Database Syst Rev. 2002;(3):CD000333. doi: 10.1002/14651858.CD000333. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2011 Jul 06;(7):CD000333. doi: 10.1002/14651858.CD000333.pub2. PMID: 12137611 Updated. Review.
441 results